Prelude Therapeutics
PRLD
#9249
Rank
A$0.10 B
Marketcap
$1.89
Share price
-4.83%
Change (1 day)
-69.23%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.26

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.48. In 2022 the company made an earnings per share (EPS) of -$3.91 a decrease over its 2021 EPS that were of -$3.88.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.26-16.6%
2022-$3.910.83%
2021-$3.88-61.3%
2020-$10.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.49 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA